Pandu Raharja was one of the first to develop state-of-the-art machine learning models to predict cancer outcomes from images. He has experience in ML, including in cancer drug design for Roche. He has 6 top-tier publications, 2 patents, won worldwide machine learning awards and 2 masters from LMU and TUM.
Company:
Panakeia
Making cancer diagnosis faster and cheaper by eliminating the need for multiple tests